Long-term multiple risk factor interventions in Japanese elderly diabetic patients: The Japanese Elderly Diabetes Intervention Trial - study design, baseline characteristics and effects of intervention

Geriatrics and Gerontology International

Volumn 12, Issue SUPPL.1, 2012, Pages 7-17

  Araki, Atsushi ^a   Iimuro, Satoshi ^b   Sakurai, Takashi ^f,g   Umegaki, Hiroyuki ^h   Iijima, Katsuya ^b,c   Nakano, Hiroshi ^d   Oba, Kenzo ^d   Yokono, Koichi ^f   Sone, Hirohito ⁱ   Yamada, Nobuhiro ⁱ   Ako, Junya ^c   Kozaki, Koichi ^c   Miura, Hisayuki ^g   Kashiwagi, Atsunori ^j   Kikkawa, Ryuichi ^j   Yoshimura, Yukio ^k   Nakano, Tadasumi ^e   Ohashi, Yasuo ^b   Ito, Hideki ^a  

^a Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NIPPON MEDICAL SCHOOL   (Japan)

^e Tokyo Metropolitan Tama Geriatric Hospital   (Japan)

^f KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^h NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ UNIVERSITY OF TSUKUBA   (Japan)

^j SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^k SHIKOKU UNIVERSITY   (Japan)

more..

Author keywords

Diabetes mellitus; Elderly; Geriatric assessment; Intervention; Vascular complications

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; INSULIN; NICOTINIC ACID; PIOGLITAZONE; PROBUCOL; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; AGED; ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; ARTICLE; ATHEROSCLEROSIS; BODY MASS; BRAIN INFARCTION; CHOLESTEROL BLOOD LEVEL; COGNITIVE DEFECT; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; GERIATRIC PATIENT; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART MUSCLE REVASCULARIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN TREATMENT; ISCHEMIC HEART DISEASE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK MANAGEMENT; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MALE; RISK FACTORS;

EID: 84858766320     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2011.00808.x     Document Type: Article

References (28)

1. Sekikawa A, Tominaga M, Takahashi K etal. Prevalence of diabetes and impaired glucose tolerance in Funagata area, Japan. Diabetes Care 1993; 16: 570-574.
2. Morgan CL, Currie CJ, Stott NC, Smithers M, Butler CC, Peters JR. The prevalence of multiple diabetes-related complications. Diabet Med 2000; 17: 146-151.
3. Gregg EW, Beckles GL, Williamson DF etal. Diabetes and physical disability among older US adults. Diabetes Care 2000; 23: 1272-1277.
4. Gregg EW, Mangione CM, Cauley JA etal. The Study of Osteoporotic Fractures Research Group. Diabetes and incidence of functional disability in older women. Diabetes Care 2002; 25: 61-67.
5. Perlmuter LC, Hakami MK, Hodgson-Harrington C etal. Decreased cognitive function in aging non-insulin-dependent diabetic patients. Am J Med 1984; 77: 1043-1048.
6. Araki A, Ito H. Asymptomatic cerebral infarction on brain MR images and cognitive function in elderly diabetic patients. Geriatr Gerontol Int 2002; 2: 206-214.
7. Black SA. Increased health burden associated with comorbid depression in older diabetic Mexican Americans. Results from the Hispanic Established Population for the Epidemiologic Study of the Elderly survey. Diabetes Care 1999; 22: 56-64.
8. Araki A, Nakano T, Oba K etal. Low well-being, cognitive impairment and visual impairment were associated with functional disabilities in elderly Japanese patients with diabetes mellitus. Geriatr Gerontol Int 2004; 4: 27-36.
9. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352 (9131): 837-853.
10. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317 (7160): 703-713.
11. Ohkubo Y, Kishikawa H, Araki E etal. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-117.
12. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393.
13. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Mid South Med J 1965; 14: 61-65.
14. Koyano W, Shibata H, Nakazato K, Haga H, Suyama Y. Measurement of competence: reliability and validity of the TMIG Index of Competence. Arch Gerontol Geriatr 1991; 13: 103-116.
15. Shibata H, Sugisawa H, Watanabe S. Functional capacity in elderly Japanese living in the community. Geriatr Gerontol Int 2001; 1: 8-13.
16. Baecke JAH, Burema J, Frijters JER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982; 36: 936-942.
17. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-193.
18. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol 1986; 5: 165-173.
19. Araki A, Ito H. Development of elderly diabetes burden scale for elderly patients with diabetes mellitus. Geriatr Gerontol Int 2003; 3: 212-224.
20. Takahashi K, Yoshimura Y, Kaigen T, Kunii D, Komatsu R, Yamamoto S. Validation of food frequency questionnaire based on food groups for estimation of individual nutrient intake. Eiyogaku Zasshi 2001; 59: 221-232. (In Japanese.)
21. Hanefeld M, Chiasson JL, Koehler C, Henkel E, Schaper F, Temelkova-Kurktschiev T. Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke 2004; 35: 1073-1078.
22. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003; 290: 486-494.
23. Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 2004; 25: 10-16.
24. Katakami N, Yamasaki Y, Hayaishi-Okano R etal. Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes. Diabetologia 2004; 47: 1906-1913.
25. Johnson JA, Simpson SH, Toth EL, Majumdar SR. Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with type 2 diabetes. Diabet Med 2005; 22: 497-502.
26. Satoh N, Ogawa Y, Usui T etal. Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect. Diabetes Care 2003; 26: 2493-2499.
27. Choi D, Kim SK, Choi SH etal. Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes. Diabetes Care 2004; 27: 2654-2660.
28. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559.